These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16682198)

  • 1. Synthesis of a potential photoactivatable anandamide analog.
    Balas L; Cascio MG; Di Marzo V; Durand T
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3765-8. PubMed ID: 16682198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.
    Balas L; Durand T; Saha S; Johnson I; Mukhopadhyay S
    J Med Chem; 2009 Feb; 52(4):1005-17. PubMed ID: 19161308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands.
    Osman NA; Mahmoud AH; Allarà M; Niess R; Abouzid KA; Di Marzo V; Abadi AH
    Bioorg Med Chem; 2010 Dec; 18(24):8463-77. PubMed ID: 21074998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
    Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A
    Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide: an update.
    Smita K; Sushil Kumar V; Premendran JS
    Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anandamide transport.
    McFarland MJ; Barker EL
    Pharmacol Ther; 2004 Nov; 104(2):117-35. PubMed ID: 15518883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cannabinoid receptor activity, and enzymatic stability of reversed amide derivatives of arachidonoyl ethanolamide.
    Parkkari T; Savinainen JR; Raitio KH; Saario SM; Matilainen L; Sirviö T; Laitinen JT; Nevalainen T; Niemi R; Järvinen T
    Bioorg Med Chem; 2006 Aug; 14(15):5252-8. PubMed ID: 16644227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide.
    Seltzman HH; Fleming DN; Thomas BF; Gilliam AF; McCallion DS; Pertwee RG; Compton DR; Martin BR
    J Med Chem; 1997 Oct; 40(22):3626-34. PubMed ID: 9357529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of a photoactivatable probe of the anandamide re-uptake.
    Balas L; Hellal M; Rossi JC; Durand T
    Nat Prod Res; 2005 Jun; 19(4):419-23. PubMed ID: 15938150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardiovascular actions of anandamide: more targets?
    Randall MD
    Br J Pharmacol; 2005 Jul; 145(5):565-6. PubMed ID: 15834438
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.
    Kaplan BL; Ouyang Y; Herring A; Yea SS; Razdan R; Kaminski NE
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):107-15. PubMed ID: 15893538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid.
    Calignano A; La Rana G; Makriyannis A; Lin SY; Beltramo M; Piomelli D
    Eur J Pharmacol; 1997 Dec; 340(2-3):R7-8. PubMed ID: 9537804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation.
    Wang H; Matsumoto H; Guo Y; Paria BC; Roberts RL; Dey SK
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14914-9. PubMed ID: 14645706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways.
    Movsesyan VA; Stoica BA; Yakovlev AG; Knoblach SM; Lea PM; Cernak I; Vink R; Faden AI
    Cell Death Differ; 2004 Oct; 11(10):1121-32. PubMed ID: 15375383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids and the gut.
    Pinto L; Capasso R; Di Carlo G; Izzo AA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide and vanilloid TRPV1 receptors.
    Ross RA
    Br J Pharmacol; 2003 Nov; 140(5):790-801. PubMed ID: 14517174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
    Fowler CJ
    Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.